HomeTrading IdeasDAX Pushes Higher as...

DAX Pushes Higher as EU Edges Closer to Tariff Deal With US

rises as investors await trade news from Trump. shows resilience despite a rise in inventories and uncertainty over trade tariffs.

The DAX, along with European indices, is inching higher on Wednesday, supported by defence stocks as investors wait for news on a trade deal with the US.

President Trump said he will probably inform the EU within the next few days what rate it can expect for exports, adding that talks with the EU had been going well.

The FT reported that EU negotiators are nearing a trade deal with the US. The market seems less concerned about trade tariffs, amid hopes that Trump will remain flexible and open to negotiation. As a result, the DAX is trading near record highs.

Yesterday, Trump announced plans to impose a 50% tariff on imported and warned of levies on semiconductors and pharmaceuticals, which would come soon. He also informed 14 countries of the new tariff levels, which take effect on August 1. However, he added that there was still time to negotiate. Today, Trump is expected to announce levies for seven more countries.

The eurozone economic calendar is quiet. Attention will be focused on ECB speakers, including Chief Economist Philip Lane, and will shift to the US session, where the will be released.

At the sector level, defence stocks have been outperforming and have traded firmly in recent months, driven by pledges from governments to increase defence spending. Banks are also performing well ahead of the start of earnings next week.

DAX Forecast – Technical Analysis

DAX is extending its recovery from 23k, rising above 24k resistance to current levels of 24,350. Buyers supported by the RSI above 50 will look to extend gains towards 24,500. Above here, there are blue skies so 25k would be the next logical target.

Support can be seen at 24k and 23,700, the confluence of the 20 and 50 SMA. A break below 23k would create a lower low.

Oil Shows Resilience Despite a Jump in Inventories

Oil prices are holding steady on Wednesday, hovering around a 2 two-week high reached in the previous session. Some markets await clarity on US tariffs, and after rising crude inventories in the US.

Figures from the API showed that US inventories gained 7.1 million barrels in the week ending July 4th, despite estimating a 2.8 million barrel draw. Typically, this would have a bearish impact on the price, especially when OPEC+ is also increasing output.

In the meeting on Saturday, the OPEC+ group agreed to increase output by a larger-than-expected 548,000 barrels per day (bpd), up from the 411,000 bpd increase over the previous months. Again, we would usually expect this news to have a bearish impact on the price; yet, oil trades around a two-week high.

The oil market is showing considerable resilience following this announcement. Instead, the market is focusing on the demand side of the equation.

Chinese inflation data turned positive in June for the first time since January, although remains in deflationary territory. rose 0.1% YoY, ahead of expectations.. China is the world’s largest importer of oil.

Furthermore, it’s peak driving season in the US, which could help support demand. There are also signs in the market that investors are less worried about the impact of Trump’s trade tariffs, on expectations that he is open to negotiation. US stocks continue to hover around record highs, and the is recovering from its 3.5-year low, trading at a 2-week high against its major peers.

If investors are less concerned about trade tariffs, this is encouraging for the growth outlook and, therefore, oil demand.

US EIA inventory data is due later today. A strong gain in inventories could pull oil lower.

Oil Forecast – Technical Analysis

Oil trades in a longer-term downward channel. However, the price recovered from the 55.30 May low and trades above its short-term rising trendline. The price is testing the 200 SMA resistance at 68.50.

Buyers, supported by momentum, will look to extend gains towards 70.00 round number and 72.30.

Failure to rise above the 200 SMA could see sellers look to test support at 65, the rising trendline support, and also the mid-point of the falling channel. Below here, 60.00 comes into play.Crude Oil-Daily Chart

Original Post

Most Popular

More from Author

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three...

Read Now

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer as Trump announced yet another delay in tariff deadlines – From the approaching July 9th to August 1st, apparently the final warning. The session began with the leading to the upside, followed by general mean-reversion all...

Gilead’s Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. GILD on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP).Through the agreement, Gilead will supply enough...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three years as investors hope for new steps to fight deflation and boost the economy. Meanwhile, dropped in London after President Donald Trump issued a new tariff warning.Asian Market WrapThe Shanghai Stock Exchange Composite Index rose...

FDA Approves New Dosing Schedule For Eli Lilly’s Kisunla In Alzheimer’s Treatment – Eli Lilly (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA approved the drug in July 2024.In the TRAILBLAZER-ALZ 6...

H2 2025: Room for Optimism, Risk for Complacency

Reasons To Be Fearful, Reasons To Be Cheerful It was an eventful first half of the year, to say the least... In January, the rise of DeepSeek was a wake-up call for the world, demonstrating that China is a major competitor to the US in AI and technology. The...

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug – Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA)

Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.Through the acquisition of this respiratory disease-focused company, Merck...

The Energy Report: Demand Exceeding Supply

It’s the oldest story in the book. Prices go up when demand exceeds supply, not only in oil and products but in wholesale power, driving up electricity costs. The Energy Information Administration (EIA) in its Short-Term Energy Outlook confirmed that we have a global supply deficit. Not only...

Altcoin Rotation Gains Steam as Bitcoin and Ethereum Take a Backseat

Despite increasing trade tensions and tariff worries, crypto continues to hold up. More than that, the group is actually performing pretty well. is leaning on a potential breakout, but it’s not doing the heavy lifting right now. To some extent, neither is . Instead, it’s more broad. Stellar,...

Oil Prices Near 2-Week Highs on OPEC+ Output and US Tariffs

climbed Tuesday, hovering near two-week highs as markets absorbed the impact of a larger-than-expected OPEC+ production increase and ongoing uncertainty around US trade policy. As of mid-afternoon, was up 89 cents at $70.47 per barrel, while US West Texas Intermediate rose 80 cents to $68.73. Both...

Oil: Can the Market Absorb OPEC+ Output Hikes?

OPEC+ surprised markets by announcing a larger-than-expected August output hike of 548,000 bpd. Analysts say actual supply increases remain limited due to ongoing compensation cuts. Strong summer demand, especially from Asia, is expected to absorb the added barrels, but demand could falter this autumn. OPEC+ never fails to surprise speculators...

US Dollar Fights an Uphill Battle Amidst Mounting Tariff Pressure

More Trump letters to be sent, with copper, chips, and pharma next on the tariff list Dollar struggles to hold recent gains, except versus the yen US equities are on the back foot, underperforming their European counterparts RBNZ stands pat; Antipodeans post small gains against the greenback Dollar Is Swimming UpstreamThe...

Big Oil Faces Weaker Quarter, but OPEC+ Output Move Signals Underlying Strength

Shell and Exxon warned of weaker Q2 earnings due to lower oil and gas prices, with Exxon expecting a $1.5 billion hit. Despite bearish forecasts, OPEC+ raised output and prices rose, suggesting demand remains stronger than expected—challenging the EV-driven demand collapse narrative. Analysts view the dip as cyclical, not...